Basket cover image
18 handpicked stocks

Largest U.S Stocks

Everything is bigger in America! This collection features some of the world's largest companies, carefully selected by our professional analysts. From tech giants to energy behemoths, these stocks represent the backbone of the American economy.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+8

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at मई 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

MSFT

Microsoft Corporation

MSFT

Current price

$509.77

AAPL

Apple, Inc.

AAPL

Current price

$230.56

GOOGL

Alphabet Inc (Google)

GOOGL

Current price

$201.57

About This Group of Stocks

1

Our Expert Thinking

These companies dominate their industries with massive market presence and global influence. We've selected these giants because they represent the power and resilience of the American economy, offering investors exposure to established market leaders with proven track records of wealth creation.

2

What You Need to Know

This collection includes diverse sectors from tech to healthcare, energy to finance. The top 6 tech companies alone were worth over $12.3 trillion in early 2024. These stocks typically offer greater stability, high liquidity, and potential for consistent long-term growth due to their established market dominance.

3

Why These Stocks

These companies weren't selected just for their size, but for their strong business models, financial stability, and innovation capabilities. Each has demonstrated resilience through economic cycles and continues to adapt to changing markets. They've historically rewarded shareholders through growth, dividends, or both.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+6.61%

Group Performance Snapshot

6.61%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 6.61% over the next year.

15 of 17

Stocks Rated Buy by Analysts

15 of 17 assets in this group are rated Buy by professional analysts.

3.5%

Group Growth

This group averaged a 3.5% return last month.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🚀

Industry Titans

These companies don't just participate in markets, they define them. With market caps in the trillions for some, they have the resources to innovate, acquire competitors, and weather economic storms better than most.

💰

Wealth Generation Machines

Many of America's largest companies have created enormous shareholder value over decades. Their combination of dividends, stock buybacks, and growth potential offers multiple ways to benefit from your investment.

🌎

Global Reach, Local Opportunity

These giants operate worldwide but you can own a piece with just a few taps. Their global diversification means they're capturing growth from developing markets while maintaining strong foundations in established ones.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.